Skip to content

Research on Acne in Unani Medicine.

Efficacy of Topical application of Zimad Irsa and Kharbaq Safed versus Zimad-e-Muhasa in Basoor-e-labaniya- A Randomized Single-Blind Comparative Clinical Trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/053460
Enrollment
40
Registered
2023-06-02
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

Intervention1: Zimad Irsa and Kharbaq Safed: Group A will be given topical Zimad Irsa and Kharbaq Safed. Required amount of the paste will be applied daily on lesions for 45 minutes followed up after

Sponsors

NATIONAL INSTITUTE OF UNANI MEDICINE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: •Clinically diagnosed cases of Acne vulgaris (Mild-Moderate). •Patients of age group 12-40years •All genders.

Exclusion criteria

Exclusion criteria: 1)Patients having severe acne with local wound and infection on face 2)Pregnant and lactating women. 3)Patient on corticosteroid therapy, anticonvulsant therapy or OCPâ??s. 4)Patients with any systemic disease like Diabetes Mellitus, Hypertension, PCOS etc. 5)Patients with any other concomitant disorders like Acne Rosacea, Acne Fulminans, Acne Necrotica, Psoriasis, Eczema etc.

Design outcomes

Primary

MeasureTime frame
Decrease in Investigator Global Assessment scale .Timepoint: Assessed at baseline 0th day, 7th day, 14th day, 21st day and 28th day.

Secondary

MeasureTime frame
â?¢Photographic changes â?¢Decrease in Cardiff Acne Disability Index. â?¢Reversal in Global Acne Grading System. Timepoint: Assessed at Baseline 0th day, 7th day, 21st day & 28th day.

Countries

India

Contacts

Public ContactDr Mohd Aleemuddin Quamri

National Institute of Unani Medicine

drmaquamri@gmail.com9341072974

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026